Elmira Mamedova

Statistics

Publications

Citations

242

H-Index

Active since

2019

Affiliations

Kyiv City Clinical Oncology Center(Current)

Beijing Ditan Hospital

Hospital Ramos Mejía

Universidade Federal da Bahia

Khon Kaen University

Elmira Mamedova is an author at Kyiv City Clinical Oncology Center specializing in antiretroviral therapy, molecular virology, and first-line antiviral therapy.

Publications per year

2019–2020

Publications

Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

Michael Aboud, Richard Kaplan, Johannes Lombaard et al. · The Lancet Infectious Diseases · 2019 · 198 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine

Julia Rozanova, Sheela Shenoi, Irina Zaviryukha et al. · Substance Use & Misuse · 2020 · 31 citations · Full text

Public Affairs, Health Policy, Geriatrics +11

Superior Efficacy of Dolutegravir (DTG) Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared with lopinavir/ritonavir (LPV/r) Plus 2 NRTIs in Second-Line Treatment — 48-week Data from the DAWNING Study

Michael Aboud, Richard Kaplan, Johannes Lombaard et al. · Journal of Infection and Public Health · 2019 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–3 of 3